Cargando…
Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098895/ https://www.ncbi.nlm.nih.gov/pubmed/25054138 http://dx.doi.org/10.1155/2014/321486 |
_version_ | 1782326400719519744 |
---|---|
author | Hung, Tzu-Chieh Lee, Wen-Yuan Chen, Kuen-Bao Chan, Yueh-Chiu Chen, Calvin Yu-Chian |
author_facet | Hung, Tzu-Chieh Lee, Wen-Yuan Chen, Kuen-Bao Chan, Yueh-Chiu Chen, Calvin Yu-Chian |
author_sort | Hung, Tzu-Chieh |
collection | PubMed |
description | Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking and molecular dynamics to regulate ESR1. S-Allylmercaptocysteine and 5-hydroxy-L-tryptophan are selected according to the highest docking score than that of other TCM compounds and Raloxifene (control). The simulation from molecular dynamics is helpful in analyzing and detecting the protein-ligand interactions. After a comparing the control and the Apo form, then based on the docking poses, hydrophobic interactions, hydrogen bond and structure variations, this research postulates that S-allylmercaptocysteine may be more appropriate than other compounds for protein-ligand interaction. |
format | Online Article Text |
id | pubmed-4098895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40988952014-07-22 Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine Hung, Tzu-Chieh Lee, Wen-Yuan Chen, Kuen-Bao Chan, Yueh-Chiu Chen, Calvin Yu-Chian Biomed Res Int Research Article Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking and molecular dynamics to regulate ESR1. S-Allylmercaptocysteine and 5-hydroxy-L-tryptophan are selected according to the highest docking score than that of other TCM compounds and Raloxifene (control). The simulation from molecular dynamics is helpful in analyzing and detecting the protein-ligand interactions. After a comparing the control and the Apo form, then based on the docking poses, hydrophobic interactions, hydrogen bond and structure variations, this research postulates that S-allylmercaptocysteine may be more appropriate than other compounds for protein-ligand interaction. Hindawi Publishing Corporation 2014 2014-06-26 /pmc/articles/PMC4098895/ /pubmed/25054138 http://dx.doi.org/10.1155/2014/321486 Text en Copyright © 2014 Tzu-Chieh Hung et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Hung, Tzu-Chieh Lee, Wen-Yuan Chen, Kuen-Bao Chan, Yueh-Chiu Chen, Calvin Yu-Chian Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title | Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title_full | Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title_fullStr | Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title_full_unstemmed | Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title_short | Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine |
title_sort | investigation of estrogen receptor (esr1) for breast cancer from traditional chinese medicine |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098895/ https://www.ncbi.nlm.nih.gov/pubmed/25054138 http://dx.doi.org/10.1155/2014/321486 |
work_keys_str_mv | AT hungtzuchieh investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine AT leewenyuan investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine AT chenkuenbao investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine AT chanyuehchiu investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine AT chencalvinyuchian investigationofestrogenreceptoresr1forbreastcancerfromtraditionalchinesemedicine |